In Small Trials, 2 Drugs Go Far in Soothing Symptoms of Eczema and Psoriasis

An experimental drug for eczema relieved severity of symptoms in 85 percent of those who took it. A drug for psoriasis cut severity of symptoms in as many as 82 percent of those who took it.

Source: NYT Health - July 9, 2014 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Johnson & Johnson JNJ NYSE Clinical Trials Skin Drugs (Pharmaceuticals) Sanofi SA SNY NYSE Eli Lilly and Company LLY NYSE Novartis AG NVS NYSE Amgen Inc AMGN NASDAQ Psoriasis Eczema Regeneron Pharmaceuticals Inc REGN NASDAQ Enbre Source Type: news